Augusto Villanueva Rodriguez MD, PhD

Dr. Augusto Villanueva Rodriguez, MD, PhD, is a nationally recognized hepatologist and physician-scientist specializing in liver diseases and liver cancer. He serves as Professor of Medicine at NYU Grossman School of Medicine and Academic Director and Medical Director of the Liver Cancer Program at NYU Langone’s Perlmutter Cancer Center, where he leads multidisciplinary efforts to advance the prevention, diagnosis, and treatment of hepatocellular carcinoma (HCC).

With extensive expertise in hepatology, Dr. Villanueva provides comprehensive care for patients with viral hepatitis, fatty liver disease, cirrhosis, autoimmune liver disorders, and other complex liver conditions. His clinical approach emphasizes personalized, collaborative care, ensuring that patients are actively involved in treatment decisions while benefiting from the latest advances in precision medicine and multidisciplinary cancer care.

An internationally recognized researcher, Dr. Villanueva has made significant contributions to the understanding of liver cancer biology, biomarker discovery, and liquid biopsy technologies for the early detection and management of hepatocellular carcinoma. His NIH-funded research has been widely published in leading medical journals, and he has been recognized among Clarivate's Highly Cited Researchers for his exceptional scientific impact. He is also an active leader in international hepatology organizations, helping shape clinical guidelines and research initiatives that improve liver cancer care worldwide.